376900 — Rokit Healthcare Income Statement
0.000.00%
- KR₩1tn
- KR₩1tn
- KR₩26bn
Annual income statement for Rokit Healthcare, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6,741 | 9,151 | 12,418 | 13,111 | 26,247 |
| Cost of Revenue | |||||
| Gross Profit | 1,655 | 3,104 | 4,047 | 5,983 | 15,688 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 24,043 | 22,938 | 19,500 | 18,717 | 25,801 |
| Operating Profit | -17,302 | -13,788 | -7,083 | -5,606 | 446 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -56,284 | 2,027 | 16,831 | -7,337 | -1,920 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -56,393 | 1,857 | 16,627 | -7,690 | -2,805 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -56,247 | 1,875 | 16,600 | -7,646 | -2,845 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -56,247 | 1,875 | 16,600 | -7,646 | -2,845 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5,844 | 186 | 1,695 | -792 | -221 |
| Dividends per Share |